DEPARTMENT OF DEFENSE
Office of the Secretary
TRICARE Over-the-Counter Drug Demonstration Project
Section 705 of the John Warner National Defense Authorization Act for 2007 directed the Secretary to conduct a demonstration project under 10 U.S.C. 1092 to allow certain over-the-counter (OTC) medications to be included on the uniform formulary under 10 U.S.C. 1074g. On June 15, 2007, the Department of Defense published a notice in theFederal Register(72 FR 33208-33210) implementing the demonstration project until the implementation of the combined TRICARE mail and retail contract (TPharm) which was on November 4, 2009. In order to more thoroughly evaluate the clinical and cost effectiveness of OTC drugs as well as beneficiary satisfaction with the project, the Department published a notice in theFederal Register(74 FR 66626-66627) on December 16, 2009 that extended the demonstration project through November 4, 2012. The Department has determined that continuation of the demonstration project for an additional 2 years is necessary to provide the Secretary with sufficient information to fully evaluate the project. The demonstration project continues to be authorized by 10 U.S.C. 1092.
Dated: October 31, 2012.
Alternate OSD Federal Register Liaison Officer, Department of Defense.